Laurent Picard

Corning (United States)

Papers

1

Total Citations

89

H-Index

1

About

Laurent Picard is a pioneering figure in the development of innovative bioanalytical tools for drug discovery, with a primary focus on G protein-coupled receptor (GPCR) technologies. His most cited work, "G protein-coupled receptor microarrays for drug discovery" (2003, 89 citations), introduced a groundbreaking high-throughput platform that enabled the parallel screening of GPCRs—a class of proteins that are targets for over a third of all modern pharmaceuticals. This contribution revolutionized early-stage drug development by allowing researchers to rapidly assess receptor-ligand interactions, significantly accelerating the identification of potential therapeutic compounds. Picard’s research bridges the gap between molecular biology and applied pharmacology, providing a robust framework for studying cell signaling and receptor function. His work has been instrumental in advancing personalized medicine and has inspired subsequent innovations in microarray-based screening technologies. With a citation record that underscores the enduring relevance of his methods, Picard remains a key influence in the field of drug discovery, particularly for researchers seeking to translate fundamental GPCR biology into tangible clinical applications.

Research Focus

Key Achievements

1
H-Index
1
Papers
89
Total Citations
89
Avg Citations/Paper
🏆 Most Cited Paper
G protein-coupled receptor microarrays for drug discovery
89 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Corning (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago